Keeps Biopharma Inc. (KOSDAQ:256940)

South Korea · Delayed Price · Currency is KRW

8,140.00

0.00 (0.00%)

At close: Feb 27, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Recycling	112.61B	81.63B	-	-	-
Recycling Growth	37.96%	-	-	-	-
OLED Business	5.77B	4.58B	-	-	-
OLED Business Growth	25.89%	-	-	-	-
Pharmaceutical and Bio Business	10.02B	6.39B	-	-	-
Pharmaceutical and Bio Business Growth	56.85%	-	-	-	-
Cross-segment Profits	-822.15M	-468.46M	-	-	-
Industrial Automation & Controls	-	-	14.62B	4.26B	15.22B
Industrial Automation & Controls Growth	-	-	243.08%	-72.00%	7.23%
Total	127.58B	92.13B	14.62B	4.26B	15.22B
Total Growth	38.48%	530.30%	243.08%	-72.00%	7.23%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
South Korea	124.33B	90.16B	14.26B	3.40B	1.77B
South Korea Growth	37.90%	532.19%	319.38%	92.62%	324.37%
China	3.26B	1.97B	339.36M	575.52M	13.30B
China Growth	65.01%	481.81%	-41.03%	-95.67%	7.77%
Other	-	-	16.65M	284.44M	148.46M
Other Growth	-	-	-94.15%	91.60%	-89.63%
Total	127.58B	92.13B	14.62B	4.26B	15.22B
Total Growth	38.48%	530.30%	243.08%	-72.00%	7.23%

Source: S&P Global Market Intelligence.